Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02535078 |
| Title | Phase 1b/2 Study of the Combination of IMCgp100 With Durvalumab and/or Tremelimumab in Cutaneous Melanoma |
| Recruitment | Withdrawn |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Immunocore Ltd |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| The Angeles Clinic and Research Institute | Los Angeles | California | 90025 | United States | Details | |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | United States | Details | |
| Thomas Jefferson University Hospital | Philadelphia | Pennsylvania | 19107 | United States | Details | |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15213 | United States | Details |